SEC 13F Intelligence

Vivo Capital, LLC / CDTX

Vivo Capital, LLC’s Cidara Therapeutics Inc Position

Does Vivo Capital, LLC own Cidara Therapeutics Inc (CDTX)? Not currently — the last reported position was 956.7K shares worth $211M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$211M
Q4 2025
Shares
956.7K
% of Portfolio
+13.66%
Quarters Held
5
position exited

Position History CDTX

Reported value by quarter
Q4 ’24: $18MQ4 ’24Q1 ’25: $15MQ1 ’25Q2 ’25: $64MQ2 ’25Q3 ’25: $126MQ3 ’25Q4 ’25: $211MQ4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2025956.7K$211M+13.66%
Q3 20251.31M$126M+10.11%
Q2 20251.31M$64M+6.54%
Q1 2025684.3K$15M+1.95%
Q4 2024670.6K$18M+2.02%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Vivo Capital, LLC’s full portfolio or all institutional holders of CDTX.